Ashland (ASH) provided an update on its $60M manufacturing network optimization plan, a key initiative under its “execute” strategy. As part of ongoing efforts to enhance operational consistency and profitability, and improve the competitive position of core technologies, the company announced the closure of its manufacturing facility in Parlin, New Jersey, and the transfer of its hydroxyethyl cellulose, or HEC, production from Parlin to its Hopewell, Virginia plant. This action is a critical step in building larger scale, improving costs across manufacturing sites and delivering the planned HEC network optimization savings in line with Ashland’s timeline. The company also announced the closure of its Chatham, New Jersey plant, and the transfer of its microbial protection production to its Freetown, Massachusetts plant, making progress on the consolidation of its smaller plants into its larger manufacturing sites. Beyond the network optimization, Ashland continues to invest in its future.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ASH:
- Ashland shares attractively valued, says JPMorgan
- Ashland’s Growth Potential: Buy Rating Backed by R&D Expansion and Strategic Sector Focus
- Ashland’s Future Prospects and Current Challenges: Hold Rating Maintained Amid Uncertainty
- Ashland’s Balanced Risk-Reward: Hold Rating Amidst Innovation Goals and Earnings Concerns